Company / Capital Expenditures
Stryker Corporation Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$761.0M
FY2025
5-year range
$487.0M / $761.0M
FY2021-FY2025
Trend
+0.8%
vs FY2024
Sector context
#13 of 151
Health Care
What the data says
Among 151 Health Care companies, Stryker Corporation is in the top 9% for capital expenditures. Capital Expenditures has increased for 3 consecutive years, from $487M in FY2022 to $761M in FY2025.
Based on SEC 10-K filings.
$761M in FY2025 with a 5-year CAGR of +5.9%. Top quartile in the Health Care sector.
Improved from $525M to $761M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +16.0%
- 5-Year CAGR
- +5.9%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 151This company $761.0M Sector average $271.7M
▼
+180.1% above sector average
Key checks
Key Insights
- Stryker Corporation's capital expenditures has grown for 3 consecutive years.
- 5-year CAGR of +5.9%, indicating consistent growth.
- In FY2025, capital expenditures increased 0.8% year-over-year.
- Ranks #13 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $761.0M | +0.8% |
| FY2024 | $755.0M | +43.8% |
| FY2023 | $525.0M | +7.8% |
| FY2022 | $487.0M | -7.2% |
| FY2021 | $525.0M | -8.2% |
| FY2020 | $572.0M | -4.3% |
| FY2019 | $598.0M | +22.0% |
| FY2018 | $490.0M | +81.5% |
| FY2017 | $270.0M | +15.9% |
| FY2016 | $233.0M | -13.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026